Skip to main content

Jeff Lagasse

By Jeff Lagasse | 02:57 pm | January 17, 2025
At the center of the project is a 186,000-square-foot tower with four operating rooms and other modern features.
By Jeff Lagasse | 11:04 am | January 17, 2025
At the top of the list are the popular semaglutides for weight loss, Ozempic, Rybelsus and Wegovy.
By Jeff Lagasse | 02:53 pm | January 16, 2025
Medicaid expansion and high marketplace enrollment are contributing to the numbers, KFF says.
By Jeff Lagasse | 10:43 am | January 16, 2025
CEO Andrew Witty promises to pass through 100% of drug rebates to consumers and wants see other companies do the same.
By Jeff Lagasse | 04:02 pm | January 15, 2025
The "Big 3" PBMs also separately generated an estimated $1.4 billion of income from spread pricing, FTC finds.
By Jeff Lagasse | 10:55 am | January 15, 2025
The county plans to restore Level II trauma care immediately once it assumes hospital operations, it says.
By Jeff Lagasse | 03:39 pm | January 14, 2025
Overall, these top 25 drugs were responsible for nearly $50 billion in total Medicare Part D spending in 2022, AARP finds.
By Jeff Lagasse | 10:48 am | January 14, 2025
CMS said RNs will be able to receive up to $40,000 for student loan debt and/or a $10,000 stipend after a three-year stint.
By Jeff Lagasse | 03:08 pm | January 13, 2025
AI is especially prevalent across biopharma, with 30% of healthcare investment in 2024 going to companies leveraging AI.
By Jeff Lagasse | 10:35 am | January 13, 2025
Some limited information may have been compromised, including Social Security numbers, IU Health says.